Re: Guymer et al.: Subthreshold nanosecond laser intervention in age-related macular degeneration: The LEAD Randomized Controlled Clinical Trial (Ophthalmology. 2019;126:829-838)

Affiliations

¹ Retina Center of Minnesota, Minneapolis, Minnesota. Electronic address: bhavs001@umn.edu.
² Paducah Retinal Center, Paducah, Kentucky.

Comment

Abdhish R Bhavsar et al. Ophthalmology. 2019 Dec.

. 2019 Dec;126(12):e91.

doi: 10.1016/j.ophtha.2019.07.016.

¹ Retina Center of Minnesota, Minneapolis, Minnesota. Electronic address: bhavs001@umn.edu.
² Paducah Retinal Center, Paducah, Kentucky.

No abstract available

Comment in

Reply.
Guymer RH, Wu Z, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Luu CD; LEAD Study Group. Guymer RH, et al. Ophthalmology. 2019 Dec;126(12):e92-e93. doi: 10.1016/j.ophtha.2019.07.017. Ophthalmology. 2019. PMID: 31759505 No abstract available.

Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration: The LEAD Randomized Controlled Clinical Trial.
Guymer RH, Wu Z, Hodgson LAB, Caruso E, Brassington KH, Tindill N, Aung KZ, McGuinness MB, Fletcher EL, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Lek JJ, Harper CA, Wickremasinghe SS, Sandhu SS, Baglin EK, Sharangan P, Braat S, Luu CD; Laser Intervention in Early Stages of Age-Related Macular Degeneration Study Group. Guymer RH, et al. Ophthalmology. 2019 Jun;126(6):829-838. doi: 10.1016/j.ophtha.2018.09.015. Epub 2018 Sep 20. Ophthalmology. 2019. PMID: 30244144 Clinical Trial.